Neuronetics Investor Relations Material

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. It offers NeuroStar advanced therapy system that enables physicians to provide office-based treatments for adult patients suffering from major depressive disorder (MDD); and maintains a registry of clinical outcomes of MDD treatment using the system. The company was founded in 1997 and is headquartered in Malvern, Pennsylvania.